ALPPS与PVE治疗剩余肝体积不足肝癌的Meta分析
该Meta分析纳入10项临床对照研究共620例患者,比较ALPPS与PVE治疗剩余肝体积不足肝癌的效果。结果显示ALPPS在二步手术完成率、FLR增长率、二步手术间隔及R0切除率上优于PVE,而90天病死率、总并发症率、肝衰竭发生率及总住院时间无显著差异。
要点
- ALPPS组二步手术完成率显著高于PVE组(OR=6.04)。
- ALPPS组FLR增长率更高、二步手术间隔更短。
- 两组90天病死率、并发症率、肝衰竭率及总住院时间无显著差异。
核心结论
- 与PVE相比,ALPPS对部分FLR不足的中晚期肝癌患者是安全有效的治疗方案。
- ALPPS和PVE的临床应用均存在一定的局限性。
研究设计与样本
- Meta分析,检索PubMed、Cochrane Library、Embase、中国知网、维普数据库。
- 纳入10篇临床对照文献(9篇队列研究,1篇随机对照研究),共620例患者,ALPPS组165例,PVE组455例。
- 采用RevMan 5.3软件进行Meta分析。
主要发现
- 二步手术完成率:OR=6.04,95%CI:2.97~12.31,Z=4.96,P<0.05。
- FLR增长率:MD=19.91,95%CI:8.64~31.18,Z=3.46,P<0.05。
- 二步手术间隔时间:MD=-30.48,95%CI:-37.87~-23.09,Z=8.09,P<0.05。
- R0切除率:OR=2.29,95%CI:1.07~4.90,Z=2.13,P<0.05。
- 90 d内病死率、总并发症发生率、术后肝功能衰竭发生率及总住院时间无统计学意义(P值均>0.05)。
临床怎么用
- 对于FLR不足的肝癌患者,ALPPS可提高二步手术完成率和R0切除率,但需权衡其局限性。
- ALPPS与PVE在90天病死率和总并发症率上无显著差异,选择术式应个体化。
局限性
- 纳入研究以队列研究为主(9篇队列研究,1篇随机对照研究),证据等级有限。
- ALPPS和PVE的临床应用均存在一定的局限性,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the feasibility, safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) and portal vein embolization (PVE) for the treatment of liver cancer with insufficient future liver remnant (FLR) . Methods: The data regarding the clinical controlled trials in comparison of ALPPS and PVE in liver surgery were collected from the both domestic and international publications searched through the datebases of PubMed, Cochrane Library, Embase, CNKI, and VIP.Meta analysis was performed by RevMan 5.3 software. Results: Total 10 studies with clinical control were analyzed (9 cohort studies and 1 randomized controlled study) .A total of 620 patients were included, with 165 cases in ALPPS group, 455 cases in PVE group.Results of Meta-analysis showed that there was statistically significant difference (P<0.05) between the two groups in the completion rate of two-steps surgery (OR=6.04, 95%CI: 2.97-12.31, Z=4.96) , FLR growth rate (MD=19.91, 95% CI: 8.64-31.18, Z=3.46) , two-steps surgical interval (MD=-30.48, 95%CI: -37.87--23.09, Z=8.09) , and R0 resection rate (OR=2.29, 95%CI=1.07-4.90, Z=2.13) .While there was no significant differences between the two groups in the mortality rate of postoperative within 90-days, postoperative the total complication rates, postoperative liver failure, and total hospital stay (all P>0.05) . Conclusions: Compared to the PVE procedures, ALPPS appears an effective treatment method for liver tumor with insufficient FLR.Therefore, the applications of ALPPS and PVE are limited and depending on further investigation. 目的: 探讨联合肝脏分隔和门静脉结扎的分阶段肝切除术(ALPPS)和门静脉栓塞(PVE)两种术式对剩余肝脏体积(FLR)不足的肝脏恶性肿瘤治疗的可行性、安全性和有效性。 方法: 检索PubMed、Cochrane Library、Embase、中国知网、维普数据库,收集国内外相关ALPPS与PVE的临床对比研究,采用RevMan 5.3进行Meta分析。 结果: 纳入10篇临床对照文献(9篇为队列研究,1篇为随机对照研究),共620例研究者(ALPPS组165例,PVE组455例)。分析结果表明,二步手术完成率(OR=6.04,95% CI:2.97~12.31,Z=4.96),FLR增长率(MD=19.91,95% CI:8.64~31.18,Z=3.46),二步手术间隔时间(MD=-30.48,95%CI:-37.87~-23.09,Z=8.09),R0切除率(OR=2.29,95%CI:1.07~4.90,Z=2.13)等差异均有统计学意义(P<0.05);而90 d内病死率、总并发症发生率、术后肝功能衰竭发生率及总住院时间无统计学意义(P值均>0.05)。 结论: 与PVE相比,ALPPS对部分FLR不足的中晚期肝癌患者是安全有效的治疗方案。但ALPPS和PVE的临床应用均存在一定的局限性。.
引用
- Cao YL, Wang GJ, Li W, et al. [Meta-analysis of the outcomes of associating liver partition and portal vein ligation for staged hepatectomy versus portal vein embolization for the treatment of liver cancer with insufficient future liver remnant]. Zhonghua Wai Ke Za Zhi. 2019. PMID: 31269618. doi:10.3760/cma.j.issn.0529-5815.2019.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。